Skip to main content

Tobramycin Sulfate Injection Shortage

Last Updated: June 5, 2019
Status: Resolved

Products Affected - Description
    • Tobramycin Sulfate solution for injection, Akorn, 40 mg/mL, 2 mL vial, 25 count, NDC 17478-0114-02 - discontinued
    • Tobramycin Sulfate solution for injection, Akorn, 40 mg/mL, 30 mL vial, 1 count, NDC 17478-0114-30 - discontinued
    • Tobramycin Sulfate solution for injection, Teva, 40 mg/mL, 2 mL vial, 25 count, NDC 00703-9402-04 - discontinued
    • Tobramycin Sulfate solution for injection, Teva, 40 mg/mL, 30 mL vial, 1 count, NDC 00703-9416-01 - discontinued
Reason for the Shortage
    • Akorn discontinued tobramycin injection in late-2018.
    • Mylan Institutional refuses to provide availability information.
    • Pfizer had tobramycin injection on shortage due to manufacturing delays.
    • Teva discontinued tobramycin injection.
Available Products
    • Tobramycin Sulfate solution for injection, Baxter, 40 mg/mL, 2 mL vial, 25 count, NDC 36000-0244-25
    • Tobramycin Sulfate solution for injection, Baxter, 40 mg/mL, 30 mL vial, 1 count, NDC 36000-0242-01
    • Tobramycin Sulfate lyophilized powder for solution for injection, Fresenius Kabi, 1.2 gram, 50 mL preservative-free vial, 6 count, NDC 63323-0303-51
    • Tobramycin Sulfate solution for injection, Fresenius Kabi, 10 mg/mL, 2 mL vial, 25 count, NDC 63323-0305-02
    • Tobramycin Sulfate solution for injection, Fresenius Kabi, 40 mg/mL, 2 mL vial, 25 count, NDC 63323-0306-02
    • Tobramycin Sulfate solution for injection, Fresenius Kabi, 40 mg/mL, 30 mL vial, 10 count, NDC 63323-0306-30
    • Tobramycin Sulfate solution for injection, Fresenius Kabi, 40 mg/mL, 50 mL vial, 1 count, NDC 63323-0307-51
    • Tobramycin Sulfate solution for injection, Pfizer, 40 mg/mL, 2 mL vial, 25 count, NDC 00409-3578-01
    • Tobramycin Sulfate lyophilized powder for solution for injection, X-Gen, 1.2 gram, 50 mL preservative-free vial, 1 count, NDC 39822-0412-01
    • Tobramycin Sulfate lyophilized powder for solution for injection, X-Gen, 1.2 gram, 50 mL preservative-free vial, 6 count, NDC 39822-0412-06

Estimated Resupply Dates

    • All marketed presentations that we are able to get information on are available.

Updated

Updated June 5, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 28, 2010 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer